Skip to content

Author

A. Bourdin

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Dupilumab efficacy and safety in patients with allergic bronchopulmonary aspergillosis.

BACKGROUND Allergic bronchopulmonary aspergillosis (ABPA) is a complex allergic hypersensitivity reaction to Aspergillus species that can complicate and worsen concomitant asthma and is associated with an intense type 2 immune response in lower airways; there are no approved targeted therapies. OBJECTIVE To investiga...

A. Bourdin, J. Corren, A. Shah et al. · 0 citations
Sep 2026

Efficacy and Tolerance of a Combination of Targeted Therapies Indicated for Asthma and Chronic Inflammatory Rheumatism.

OBJECTIVE The use of combined targeted therapies is increasing in clinical practice, both within and across diseases. However, data on dual targeted therapy for patients with both chronic inflammatory rheumatism (CIR) and severe allergic asthma remain limited, especially regarding treatment outcomes and safety, includi...

L. Etronnier, Cédric Lukas, Baptiste Gérard et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.